AKR7A3 and hepatocellular carcinoma: The down-regulation of AKR7A3 was also significantly associated with poor overall survival rate (*P = 0.031) (Figure 1B), elevated serum AFP level (***P < 0.001) (Table 1) and poor differentiation of HCC (*P = 0.011) (Table 1).